Back to top

LivaNova’s Aura6000 Sleep Apnea Trial Reaches Key Completion Milestone

LivaNova PLC ($LIVN) announced an update on their ongoing clinical study. The study “Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Ne...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

LivaNova PLC (LIVN)